RetaMaps

Retatrutide in New York City, NY: status & local weight-loss providers

Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.

Phase 3 complete · Not FDA-approvedRetatrutide: Phase 3 complete · FDA submission planned Q1 2027 · Not available outside trials / expanded access. Tracker
116
tracked providers
9
advertise GLP-1 medications today
60
offer telehealth
30
have 100+ Google reviews

Karin Chen, MD

110 E 59TH ST, SUITE 8B · New York, NY 10022

5.0(1 Google review · 1 in past year)

TelehealthCash pay
View profile
Listing updated Oct 2, 2026

Pins reflect street addresses where available; others are approximate (ZIP-level).

Want retatrutide when it's available in New York City?

Be first to know when its status changes — join thousands already on the list.

Nearby markets

Bronx (1)The Bronx (16)Yonkers (5)Flushing (1)Queens (29)Forest Hills (1)All of New York →

Learn about retatrutide

FDA approval trackerWhat is retatrutide? The complete guide to the triple hormone agonist"Research peptide" retatrutide: what you're actually buyingHow to choose a weight-loss doctor (and the red flags to walk away from)When will retatrutide be available?

Frequently asked questions

Can I get retatrutide in New York City today?

No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in New York City or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.

What do the providers listed for New York City actually offer?

They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.

Are telehealth options tracked for New York City?

Yes — 60 of the 116 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve New York residents; confirm with the practice.

Does being listed mean a New York City provider will prescribe retatrutide?

No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.

How do I hear when availability changes near New York City?

Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.